US20060018943A1 - Antimicrobial material for implanting in bones - Google Patents

Antimicrobial material for implanting in bones Download PDF

Info

Publication number
US20060018943A1
US20060018943A1 US11/198,567 US19856705A US2006018943A1 US 20060018943 A1 US20060018943 A1 US 20060018943A1 US 19856705 A US19856705 A US 19856705A US 2006018943 A1 US2006018943 A1 US 2006018943A1
Authority
US
United States
Prior art keywords
antimicrobial
aggregates
powder
material
silver
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US11/198,567
Inventor
Thorsten Bechert
Peter Steinruecke
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BIO-GATE AG
Original Assignee
Bio-Gate Bioinnovative Materials GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to DE10043151.8 priority Critical
Priority to DE2000143151 priority patent/DE10043151A1/en
Priority to PCT/DE2001/003210 priority patent/WO2002017984A1/en
Priority to US10/363,120 priority patent/US6984392B2/en
Application filed by Bio-Gate Bioinnovative Materials GmbH filed Critical Bio-Gate Bioinnovative Materials GmbH
Priority to US11/198,567 priority patent/US20060018943A1/en
Publication of US20060018943A1 publication Critical patent/US20060018943A1/en
Assigned to BIO-GATE AG reassignment BIO-GATE AG MERGER (SEE DOCUMENT FOR DETAILS). Assignors: BIO-GATE BIOINNOVATIVE MATERIALS GMBH
Application status is Abandoned legal-status Critical

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION, OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES
    • A61L31/00Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/16Biologically active materials, e.g. therapeutic substances
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION, OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES
    • A61L24/00Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/001Use of materials characterised by their function or physical properties
    • A61L24/0015Medicaments; Biocides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION, OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/28Materials for coating prostheses
    • A61L27/34Macromolecular materials
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION, OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/40Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
    • A61L27/44Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix
    • A61L27/446Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix with other specific inorganic fillers other than those covered by A61L27/443 or A61L27/46
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION, OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54Biologically active materials, e.g. therapeutic substances
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION, OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES
    • A61L29/00Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
    • A61L29/08Materials for coatings
    • A61L29/085Macromolecular materials
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION, OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES
    • A61L29/00Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
    • A61L29/12Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
    • A61L29/126Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION, OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES
    • A61L29/00Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
    • A61L29/14Materials characterised by their function or physical properties, e.g. lubricating compositions
    • A61L29/16Biologically active materials, e.g. therapeutic substances
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION, OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES
    • A61L31/00Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/08Materials for coatings
    • A61L31/10Macromolecular materials
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION, OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES
    • A61L31/00Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/12Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
    • A61L31/125Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix
    • A61L31/128Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix containing other specific inorganic fillers not covered by A61L31/126 or A61L31/127
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION, OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/10Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing inorganic materials
    • A61L2300/102Metals or metal compounds, e.g. salts such as bicarbonates, carbonates, oxides, zeolites, silicates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION, OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/10Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing inorganic materials
    • A61L2300/102Metals or metal compounds, e.g. salts such as bicarbonates, carbonates, oxides, zeolites, silicates
    • A61L2300/104Silver, e.g. silver sulfadiazine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION, OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404Biocides, antimicrobial agents, antiseptic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION, OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/606Coatings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION, OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/62Encapsulated active agents, e.g. emulsified droplets
    • A61L2300/624Nanocapsules
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION, OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES
    • A61L2430/00Materials or treatment for tissue regeneration
    • A61L2430/02Materials or treatment for tissue regeneration for reconstruction of bones; weight-bearing implants

Abstract

The invention relates to an antimicrobial material for implanting in bones and for coating or producing an implant or an implantable medical device, whereby particles formed from an antimicrobial material are remotely dispersed inside a matrix material that forms a matrix when hardened. In order to improve the compatibility of the antimicrobial material, the invention provides that the metal is formed from aggregates of primary particles having an average particle size ranging from 10 to 100 nm.

Description

  • This application is a continuation of U.S. application Ser. No. 10/363,120, filed Apr. 28, 2003, which application is a national stage application under 35 USC § 371 and claims benefit under 35 USC § 119(a) of International Application No. PCT/DE01/03210 having an International filing date of Aug. 28, 2001, which claims benefit of DE 100 43 151.8 filed on Aug. 31, 2000.
  • The invention relates to an antimicrobial material for implanting in bones, for coating or producing implants or an implantable device corresponding to the preamble of claim 1. It further relates to a process for producing such a material.
  • EP 0 190 504 discloses an antimicrobial composition which contains 5 to 10% by weight of silver. In addition, to improve the antimicrobial properties, a hydratable or a hydrated oxide is added.
  • DE 31 10 681 C2 describes a material for bone implants. The material is produced from a polymer to which silver phosphate is added as antimicrobial agent.
  • WO 81/02667 discloses an antimicrobial surgical implant. Metallic silver is added to the implant as antimicrobial agent.
  • The generic WO 82/01990 describes a bone cement based on polymethylmethacrylate as main component, to which 5% by volume of a silver salt is added as antimicrobial agent.
  • U.S. Pat. No. 5,837,275 discloses an antimicrobial material which contains, inter alia, silver particles with a particle size of less than 200 nm. The silver lattice has lattice disorders and defects in order to facilitate release of silver ions.
  • WO 84/01721 discloses a material provided with silver sulfate or silver acetate. This material releases a concentration of more than 1 μM silver ions in a surrounding fluid within 24 hours.
  • DE 32 288 849 A1 describes a material with a coating made of silver. Elemental carbon or titanium is added to the material. The addition is intended to facilitate increased release of silver ions into the surroundings.
  • U.S. Pat. No. 4,849,233 discloses a bone cement to which about 10% by weight of elemental silver plus titanium oxide or tantalum oxide are added. The bone cement is distinguished by a high rate of release of silver ions.
  • The antimicrobial activity of the materials disclosed in the prior art has been detected using the so-called measurement of zones of inhibition. Measurement of zones of inhibition is described, for example, in Raad I. et al., J. Infec. Dis. 173 (1996). This entails the material to be tested being embedded in a nutrient medium, e.g. agar. A zone of inhibition forms around the material because of the release of metal ions with antimicrobial activity. The formation and the size of such a zone of inhibition has been regarded in the prior art as indicating the antimicrobial activity of the material. The materials known in the prior art have in some cases the disadvantage that they release a sufficiently high concentration of silver ions for only a relatively short time. Their antimicrobial activity is restricted to this time. In order to counteract this disadvantage, relatively large amounts of metals with antimicrobial activity are added in the prior art. This in turn leads to unwanted cytotoxic effects in vivo.
  • It is an object of the invention to eliminate the disadvantages of the prior art. It is intended in particular to indicate an antimicrobial material which has improved properties and which can be produced as easily and inexpensively as possible. The tolerability of the material by the patient should be maximal. It is additionally intended to indicate a process for producing the antimicrobial material.
  • This object is achieved by the features of claims 1 and 14. Expedient embodiments are evident from the features of claims 2 to 13 and 15 to 27.
  • The invention provides for the metal to be formed from aggregates of primary particles having an average particle size between 10 and 100 nm.
  • The primary particles in the aggregates of the invention can still be identified on the basis of their external shape. The primary particles are bound together essentially by necks formed during sintering. The aggregates form a highly porous framework structure. The matrix material may, depending on the particular embodiment, be essentially bioinert.
  • The proposed material is distinguished by an excellent antimicrobial activity. A sufficiently high concentration of silver ions is made available on the surface of the material. Moreover the rate of diffusion of silver ions into the surrounding tissue is particularly low. This means that the antimicrobial activity remains confined to the surface of the material. It is possible with the material of the invention to produce, for example, bone cements, implants or else implantable devices such as catheters, with improved antimicrobial properties. No unwanted cytotoxic effects occur. The antimicrobial effect of the material is particularly long-lasting. The pharmacological stress on the patient is less.
  • In an advantageous embodiment, the aggregates have an average particle size of from 1 to 20 μm, preferably 10 to 20 μm. The surface area of the aggregates is expediently from 3 to 6 m2/g. They may have a porosity of up to 95%. The porosity is expediently between 70 and 95%. The aforementioned features contribute to a uniform and cytotoxically unobjectionable delivery of silver ions on the surface of the material.
  • The aggregates can be produced by inert gas vaporization and condensation, preferably under a pressure of from 10 to 100 mbar of inert gas. The metal may be formed from one or more of the following components: Ag, Au, Pt, Pd, Ir, Sn, Cu, Sb, Zn. The metal expediently has an essentially undisordered lattice structure. This avoids undesirably high release of silver ions into the surrounding tissue.
  • According to a particularly advantageous embodiment feature, the metal content is not more than 2% by weight, preferably 0.01 to 2% by weight, based on the weight of the matrix material. Silver is expediently used as metal. The proposed addition of metal is relatively small. The material can be produced inexpensively.
  • It has further proved to be expedient for the aggregates to be completely infiltrated with the matrix material. It is advantageous for the aggregates to be homogeneously dispersed or distributed in the matrix material. These features contribute to the amount of silver ions released always being the same at all sites on the surface of the material.
  • The matrix material may be a polymer preferably formed from a plurality of components. The polymer may essentially comprise acrylic esters and/or methacrylic esters. However, other matrix materials used in the prior art for producing bone cements are also suitable as matrix material.
  • The proposed antimicrobial material is suitable for producing or else for coating implants or an implantable medical device, e.g. a catheter or intratracheal tubes. It is possible in particular to use the proposed antimicrobial material to coat or produce hip joint implants, heart valves, stents, knee joint implants, dental fillings, contact lenses or intraocular lenses, produced, for example, from titanium or ceramic.
  • In addition, a process for producing the material according to the invention is proposed, having the following steps:
      • a) vaporization and condensation of metal under inert gas atmosphere, where the pressure of the inert gas and the vaporization temperature are adjusted so that aggregates consisting of primary particles having an average particle size of from 10 to 100 nm are formed, and
      • b) mixing of the aggregates with a curable matrix material.
  • The proposed process is relatively easy to carry out. It is possible thereby to produce the antimicrobial material in uniform quality and relatively inexpensively.
  • According to one embodiment feature, the aggregates are classified after step a). It is expedient for a particle size fraction of the aggregates in the range from 1 to 20 μm preferably 10 to 20 μm to be mixed with the matrix material, which is preferably in the liquid state. The particle size fraction can be stirred into the matrix material.
  • It has proved to be expedient to use an inert gas which comprises as an essential component at least one of the following gases: argon, krypton, xenon, helium.
  • Reference is made to the preceding statements concerning further advantageous embodiments. The features described there can also be applied analogously in the process.
  • Exemplary embodiments of the invention are described in detail below with reference to the drawing.
  • These show
  • FIG. 1 bacterial proliferation on bone cements, comparing silver powders of the prior art and the silver powder of the invention,
  • FIG. 2 a scanning electron micrograph of a silver aggregate,
  • FIG. 3 the dependence of the cytotoxicity of a bone cement as a function of the silver content and
  • FIG. 4 a zone of inhibition test for various bone cements.
  • The results shown in FIG. 1 were obtained by the method disclosed in DE 197 51 581 A1. This method is further described in Bechert, Thorsten et al., Nature Medicine, Vol. 6, No. 8 (September 2000). The disclosure of both the aforementioned documents is incorporated herein by reference.
  • Initially in each case 8 parallel samples (A-H) are made from the same batch of bone cement. The samples are normally cylindrical in shape. They have a length of about 1 cm and a diameter of from 2 to 5 mm. Subsequently, 200 μl of a bacteria-containing solution are introduced into each well of a microtiter plate. The samples are incubated at 37° C. for one hour. The samples are then removed and washed three times with physiological buffers. The samples are then placed in the wells of a microtiter plate which are filled with a minimal medium. 200 μl of minimal medium are introduced into each well. The samples are incubated at 37° C. for 24 hours. The samples are then removed and discarded. 50 μl of a complete medium (trypticase soya) are added to each well of the microtiter plate. The turbidity of the solution is then measured at 30-minute intervals over a period of 48 hours. The solution is kept at a temperature of 37° C. during this. The turbidity is measured by means of a suitable reader using light of a wavelength of 578 nm. A turbidity indicates that bacteria have been released from the surface of the sample into the surroundings.
  • FIG. 1 shows a comparison of a bone cement to which various contents of conventional silver powder supplied by Chempur (columns 2-6) have been added with a second bone cement to which comparable amounts of silver aggregates of the invention have been added (columns 7 to 11).
  • 2.0% by weight of silver have been added to the samples of columns 2 and 7, 1.0% by weight of silver to the samples of columns 3 and 8, 0.5% by weight of silver to the samples of columns 4 and 9, 0.1% by weight of silver to the samples of columns 5 and 10 and 0.05% by weight of silver to the samples of columns 6 and 11. Column 12 shows the results of samples without added silver (control).
  • It is evident that addition of only 1.0% by weight of silver aggregates of the invention results in an excellent antimicrobial activity. When conventional silver powders are used, no reliable antimicrobial activity is achieved even on addition of 2.0% by weight.
  • FIG. 2 shows a scanning electron micrograph of the silver aggregate of the invention. The silver aggregate consists essentially of spherical primary particles with an average particle size of about 20 nm. The primary particles are essentially connected together by necks formed during sintering. They form a highly porous structure. The silver aggregate shown here has a size of about 10 μm.
  • FIG. 3 shows the results of the cytotoxic effect of the bone cements of the invention. The method used here was the test of Greil et al. (Infection, Vol. 27, 1999, Suppl. 1, pp. 34-37). This entails a tetrazole dye (MTT) being converted into an intensely colored formazan by a vital cell line showing respiratory activity (MRC-5 cells or by phytohemagglutinin-stimulated lymphocytes). The extent of the coloration achieved in a predefined time period is a measure of the vitality of the cells. The test is carried out in accordance with the ISO guideline. For this purpose, initially samples are incubated extracts of the bone cement with culture medium at 37° C. for 24 hours. The samples are incubated in the formazan assay together with the cells for a period of 72 hours. The cytotoxicity is defined as the relative percentage loss of respiratory activity through formazan formation as a consequence of addition of the extract.
  • Extracts obtained in accordance with the ISO guideline from PVC in independent experiments served as positive control. Cytotoxicity levels of greater than or equal to 30% are regarded as cytotoxic effects. The controls used were extracts of PE (negative control) and PVC (positive control).
  • FIG. 3 a shows the result of an extract diluted 1:10 for positive control with lymphocytes. The cytotoxicity in this case is 100%.
  • FIG. 3 b shows the result of the positive control with MRC-5 cells. The cytotoxicity in this case is 60%.
  • FIG. 3 c shows the result using a bone cement of the invention with addition of 1.0% by weight of silver aggregate. The cytotoxicity in this case was only 8.4% for lymphocytes and 4.8% for MRC-5 cells (FIG. 3 d).
  • FIG. 4 shows the results of a measurement of the zone of inhibition with bone cements of the invention compared with conventional bone cements. The sample composition was as follows:
      • sample a: bone cement with 0.05% by weight of silver aggregates,
      • sample b: bone cement with 0.1% by weight of silver aggregates,
      • sample c: bone cement with 0.5% by weight of silver aggregates,
      • sample d: bone cement with 2.0% by weight of silver aggregates,
      • sample e: bone cement with 5.0% by weight of silver aggregates,
      • sample f: conventional gentamycin-containing bone cement (Merck “Palacos”)
      • sample g, h: conventional bone cements without additions (Merck “Palacos”).
  • Samples a to h had, in order to carry out the measurement of the zones of inhibition, been embedded in a Muller-Hinton agar which had been incubated with coagulase-negative staphylococci as test microbe for 24 hours. No zone of inhibition is evident with the bone cements containing silver aggregates. By contrast, the conventional gentamycin-containing bone cement shows a clear zone of inhibition. The bone cements of the invention thus release only a small concentration of silver ions into the surroundings.

Claims (12)

1. An antimicrobial powder comprising discrete aggregates formed from an antimicrobial metal, wherein the aggregates are highly porous and are formed of primary particles connected together by necks, the primary particles having an average size between 10 and 100 nm.
2. The antimicrobial powder as in claim 1, wherein the aggregates have an average aggregate size of from 1 to 20 μm.
3. The antimicrobial powder as in claim 2, wherein the aggregates have an average aggregate size of from 10 to 20 μm.
4. The antimicrobial powder as in claim 1, 2, or 3, wherein the aggregates have a surface area of from 3 to 6 m2 per gram.
5. The antimicrobial powder as in claim 1, 2, or 3, wherein the aggregates have a porosity of up to 95%.
6. The antimicrobial powder as in claim 1, wherein the aggregates are produced by inert gas vaporization and condensation.
7. The antimicrobial metal powder of claim 6, wherein the aggregates are produced under a pressure of from 10 to 100 mbar of inert gas.
8. The antimicrobial powder as in claim 1, wherein the metal is formed from one or more of the following components: Ag, Au, Pt, Pd, Ir, Sn, Cu, Sb, Zn.
9. The antimicrobial powder as in claim 1, wherein the metal has an essentially undisordered lattice structure.
10. The antimicrobial powder as in claim 1, 2, or 3, wherein said primary particles have a generally spherical shape.
11. An antimicrobial material including a matrix material made of a polymer and containing the antimicrobial powder according to one of claims 1, 2 or 3.
12. The antimicrobial material of claim 11, wherein the polymer comprises an acrylic ester and/or a methacrylic ester.
US11/198,567 2000-08-31 2005-08-05 Antimicrobial material for implanting in bones Abandoned US20060018943A1 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
DE10043151.8 2000-08-31
DE2000143151 DE10043151A1 (en) 2000-08-31 2000-08-31 Bone cement with antimicrobial activity
PCT/DE2001/003210 WO2002017984A1 (en) 2000-08-31 2001-08-28 Antimicrobial material for implanting in bones
US10/363,120 US6984392B2 (en) 2000-08-31 2001-08-28 Antimicrobial material for implanting in bones
US11/198,567 US20060018943A1 (en) 2000-08-31 2005-08-05 Antimicrobial material for implanting in bones

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11/198,567 US20060018943A1 (en) 2000-08-31 2005-08-05 Antimicrobial material for implanting in bones
US12/212,181 US20090010981A1 (en) 2000-08-31 2008-09-17 Antimicrobial material for implanting in bones

Related Parent Applications (2)

Application Number Title Priority Date Filing Date
PCT/DE2001/003210 Continuation WO2002017984A1 (en) 2000-08-31 2001-08-28 Antimicrobial material for implanting in bones
US10/363,120 Continuation US6984392B2 (en) 2000-08-31 2001-08-28 Antimicrobial material for implanting in bones

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US12/212,181 Continuation US20090010981A1 (en) 2000-08-31 2008-09-17 Antimicrobial material for implanting in bones

Publications (1)

Publication Number Publication Date
US20060018943A1 true US20060018943A1 (en) 2006-01-26

Family

ID=7654674

Family Applications (3)

Application Number Title Priority Date Filing Date
US10/363,120 Active 2021-10-10 US6984392B2 (en) 2000-08-31 2001-08-28 Antimicrobial material for implanting in bones
US11/198,567 Abandoned US20060018943A1 (en) 2000-08-31 2005-08-05 Antimicrobial material for implanting in bones
US12/212,181 Abandoned US20090010981A1 (en) 2000-08-31 2008-09-17 Antimicrobial material for implanting in bones

Family Applications Before (1)

Application Number Title Priority Date Filing Date
US10/363,120 Active 2021-10-10 US6984392B2 (en) 2000-08-31 2001-08-28 Antimicrobial material for implanting in bones

Family Applications After (1)

Application Number Title Priority Date Filing Date
US12/212,181 Abandoned US20090010981A1 (en) 2000-08-31 2008-09-17 Antimicrobial material for implanting in bones

Country Status (6)

Country Link
US (3) US6984392B2 (en)
EP (2) EP1313518B1 (en)
AU (1) AU9161101A (en)
DE (2) DE10043151A1 (en)
ES (2) ES2582940T3 (en)
WO (1) WO2002017984A1 (en)

Cited By (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060105010A1 (en) * 2002-10-12 2006-05-18 Martin Rahe Bladder implant
US20070081958A1 (en) * 2003-08-29 2007-04-12 Thorsten Bechert Body care product containing porous silver particles
US20070213679A1 (en) * 2002-02-11 2007-09-13 Bio-Gate Bioinnovative Materials Gmbh Absorbent sanitary article for absorbing body fluid
US20070231135A1 (en) * 2006-03-31 2007-10-04 Orqis Medical Corporation Rotary Blood Pump
US20080089797A1 (en) * 2003-09-18 2008-04-17 Wampler Richard K Rotary Blood Pump
US20080114339A1 (en) * 2006-03-23 2008-05-15 The Penn State Research Foundation Heart assist device with expandable impeller pump
US20090010981A1 (en) * 2000-08-31 2009-01-08 Bio-Gate Ag Antimicrobial material for implanting in bones
US20090060743A1 (en) * 2004-09-17 2009-03-05 The Penn State Research Foundation Expandable impeller pump
US20090191260A1 (en) * 2006-02-23 2009-07-30 Bio-Gate Ag Aerosol and use thereof
US20100016960A1 (en) * 1997-10-09 2010-01-21 Bolling Steven F Implantable Heart Assist System And Method Of Applying Same
US20100136073A1 (en) * 2007-04-18 2010-06-03 Ciba Corporation Antimicrobial plastics and coatings
US20110004046A1 (en) * 2009-07-01 2011-01-06 The Penn State Research Foundation Blood pump with expandable cannula
WO2012123273A1 (en) 2011-03-11 2012-09-20 Basf Se Antimicrobial coating
US8485961B2 (en) 2011-01-05 2013-07-16 Thoratec Corporation Impeller housing for percutaneous heart pump
US8591393B2 (en) 2011-01-06 2013-11-26 Thoratec Corporation Catheter pump
US8597170B2 (en) 2011-01-05 2013-12-03 Thoratec Corporation Catheter pump
US8721517B2 (en) 2012-05-14 2014-05-13 Thoratec Corporation Impeller for catheter pump
US9138518B2 (en) 2011-01-06 2015-09-22 Thoratec Corporation Percutaneous heart pump
US9308302B2 (en) 2013-03-15 2016-04-12 Thoratec Corporation Catheter pump assembly including a stator
US9327067B2 (en) 2012-05-14 2016-05-03 Thoratec Corporation Impeller for catheter pump
US9358329B2 (en) 2012-07-03 2016-06-07 Thoratec Corporation Catheter pump
US9381288B2 (en) 2013-03-13 2016-07-05 Thoratec Corporation Fluid handling system
US9421311B2 (en) 2012-07-03 2016-08-23 Thoratec Corporation Motor assembly for catheter pump
US9446179B2 (en) 2012-05-14 2016-09-20 Thoratec Corporation Distal bearing support
US9675739B2 (en) 2015-01-22 2017-06-13 Tc1 Llc Motor assembly with heat exchanger for catheter pump
US9675738B2 (en) 2015-01-22 2017-06-13 Tc1 Llc Attachment mechanisms for motor of catheter pump
US9770543B2 (en) 2015-01-22 2017-09-26 Tc1 Llc Reduced rotational mass motor assembly for catheter pump
US9827356B2 (en) 2014-04-15 2017-11-28 Tc1 Llc Catheter pump with access ports
US9833472B2 (en) 2012-11-16 2017-12-05 Heraeus Medical Gmbh Antiseptic polymethylmethacrylate bone cement
US9872947B2 (en) 2012-05-14 2018-01-23 Tc1 Llc Sheath system for catheter pump
US9907890B2 (en) 2015-04-16 2018-03-06 Tc1 Llc Catheter pump with positioning brace
US10029037B2 (en) 2014-04-15 2018-07-24 Tc1 Llc Sensors for catheter pumps
US10105475B2 (en) 2014-04-15 2018-10-23 Tc1 Llc Catheter pump introducer systems and methods

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10146050B4 (en) * 2001-09-18 2007-11-29 Bio-Gate Ag A process for producing an antimicrobial adhesive and coating material
DE10243132B4 (en) * 2002-09-17 2006-09-14 Biocer Entwicklungs Gmbh The anti-infective, biocompatible titanium oxide coatings for implants and methods for their preparation
DE10340276B4 (en) * 2003-08-29 2006-11-09 Bio-Gate Bioinnovative Materials Gmbh Personal care products with silver and zinc
DE10359338B4 (en) * 2003-12-17 2007-07-19 Heraeus Kulzer Gmbh Antimicrobial nanosilver additive for polymerisable dental materials
DE102004047568A1 (en) * 2004-09-24 2006-04-13 Aesculap Ag & Co. Kg Antimicrobial implant with a flexible porous structure
WO2006056482A1 (en) 2004-11-29 2006-06-01 Dsm Ip Assets B.V. Method for reducing the amount of migrateables of polymer coatings
JP2009518479A (en) 2005-12-09 2009-05-07 ディーエスエム アイピー アセッツ ビー.ブイ. The hydrophilic coating comprising a polymer electrolyte
US20070196642A1 (en) * 2006-02-17 2007-08-23 Feldstein Michael D Coating for biological rejuvenation
CN101184512B (en) 2006-04-07 2012-09-05 防菌公司 Antimicrobial substrates and uses thereof
WO2008031601A1 (en) * 2006-09-13 2008-03-20 Dsm Ip Assets B.V. Antimicrobial hydrophilic coating comprising metallic silver particles
EP2061526B1 (en) 2006-09-13 2015-07-29 DSM IP Assets B.V. Coated medical device
MX339467B (en) 2007-02-28 2016-05-27 Dsm Ip Assets Bv Hydrophilic coating.
EP2125061A2 (en) 2007-02-28 2009-12-02 DSM IP Assets B.V. Hydrophilic coating
WO2008122596A2 (en) * 2007-04-05 2008-10-16 Cinvention Ag Curable therapeutic implant composition
DE102007019768A1 (en) 2007-04-25 2008-11-13 Thüringisches Institut für Textil- und Kunststoff-Forschung e.V. A process for producing a bioactive cellulose fiber having high whiteness
BRPI0812471A2 (en) * 2007-06-11 2017-06-13 Basf Se polyolefin or polyester composition with durable antimicrobial activity, a process for providing lasting antimicrobial activity in relation to polyolefin or polyester compositions, and use of an antimicrobial silver and an additive wettability
US20110024355A1 (en) * 2007-10-10 2011-02-03 Polymers Crc Ltd. Antimicrobial membranes
JP5788179B2 (en) 2008-02-29 2015-09-30 スミス アンド ネフュー インコーポレーテッド Coatings and coating methods
US8753561B2 (en) * 2008-06-20 2014-06-17 Baxter International Inc. Methods for processing substrates comprising metallic nanoparticles
US8178120B2 (en) * 2008-06-20 2012-05-15 Baxter International Inc. Methods for processing substrates having an antimicrobial coating
US8277826B2 (en) 2008-06-25 2012-10-02 Baxter International Inc. Methods for making antimicrobial resins
US9242026B2 (en) 2008-06-27 2016-01-26 Sofradim Production Biosynthetic implant for soft tissue repair
US20090324738A1 (en) * 2008-06-30 2009-12-31 Baxter International Inc. Methods for making antimicrobial coatings
DE102008033224A1 (en) 2008-07-15 2010-01-21 Bio-Gate Ag A process for producing a composite material with antimicrobial action
US8353856B2 (en) 2008-11-05 2013-01-15 Abbott Medical Optics Inc. Glaucoma drainage shunts and methods of use
US20100227052A1 (en) * 2009-03-09 2010-09-09 Baxter International Inc. Methods for processing substrates having an antimicrobial coating
US8702639B2 (en) * 2009-03-26 2014-04-22 Abbott Medical Optics Inc. Glaucoma shunts with flow management and improved surgical performance
WO2011066391A2 (en) 2009-11-25 2011-06-03 Difusion Technologies, Inc. Post-charging of zeolite doped plastics with antimicrobial metal ions
EP2512538B1 (en) 2009-12-11 2017-02-22 Difusion Technologies, Inc. Method of manufacturing antimicrobial implants of polyetheretherketone
US8673018B2 (en) * 2010-02-05 2014-03-18 AMx Tek LLC Methods of using water-soluble inorganic compounds for implants
CA2795836C (en) 2010-05-07 2015-11-17 Difusion Technologies, Inc. Medical implant comprising a thermoplastic resin having aluminosilicate particles incorporated therein
BR112012032202A2 (en) 2010-06-16 2016-11-22 Dsm Ip Assets Bv coating formulation for preparing a hydrophilic coating.
US10143196B2 (en) 2010-07-09 2018-12-04 Oerlikon Surface Solutions Ag, Pfäffikon Antibacterial medical product and method for producing same
FR2972626B1 (en) 2011-03-16 2014-04-11 Sofradim Production Prosthesis comprising a knitted spacer fabric and openwork
FR2977790B1 (en) 2011-07-13 2013-07-19 Sofradim Production Prosthesis for umbilical hernia
FR2977789B1 (en) 2011-07-13 2013-07-19 Sofradim Production Prosthesis for umbilical hernia
FR2985170B1 (en) 2011-12-29 2014-01-24 Sofradim Production Prosthesis for inguinal hernia
US9452032B2 (en) 2012-01-23 2016-09-27 Biomet 3I, Llc Soft tissue preservation temporary (shell) immediate-implant abutment with biological active surface
US8425231B1 (en) 2012-01-23 2013-04-23 Mark N. Hochman Soft-tissue preservation temporary (shell) immediate-implant abutment method and device
US9089382B2 (en) 2012-01-23 2015-07-28 Biomet 3I, Llc Method and apparatus for recording spatial gingival soft tissue relationship to implant placement within alveolar bone for immediate-implant placement
JP5991465B2 (en) * 2012-04-27 2016-09-14 住友電工焼結合金株式会社 Individual identification method of the sintered product
US20130306090A1 (en) * 2012-04-27 2013-11-21 Zhenbiao Wang Antimicrobial artificial nail product
EP2662051A1 (en) * 2012-05-11 2013-11-13 Dentsply IH AB Medical device having a surface comprising nanoparticles
FR2995788B1 (en) 2012-09-25 2014-09-26 Sofradim Production Hemostatic patch and method of preparation
FR2995779B1 (en) 2012-09-25 2015-09-25 Sofradim Production Prothese including a mesh and a consolidation means
US20140154297A1 (en) 2012-10-30 2014-06-05 Baxter Healthcare S.A. Antimicrobial substrates and methods for processing the same
US9700390B2 (en) 2014-08-22 2017-07-11 Biomet 3I, Llc Soft-tissue preservation arrangement and method
EP3059255A1 (en) 2015-02-17 2016-08-24 Sofradim Production Method for preparing a chitosan-based matrix comprising a fiber reinforcement member
EP3085337A1 (en) 2015-04-24 2016-10-26 Sofradim Production Prosthesis for supporting a breast structure
DE102016212091A1 (en) 2016-07-04 2018-01-04 Heraeus Medical Gmbh Antiseptic polymethylmethacrylate bone cement

Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4592920A (en) * 1983-05-20 1986-06-03 Baxter Travenol Laboratories, Inc. Method for the production of an antimicrobial catheter
US4849223A (en) * 1984-12-28 1989-07-18 Johnson Matthey Public Limited Company Antimicrobial compositions consisting of metallic silver combined with titanium oxide or tantalum oxide
US5171579A (en) * 1991-10-11 1992-12-15 Genetics Institute, Inc. Formulations of blood clot-polymer matrix for delivery of osteogenic proteins
US5356629A (en) * 1991-07-12 1994-10-18 United States Surgical Corporation Composition for effecting bone repair
US5590387A (en) * 1993-10-27 1996-12-31 H. C. Starck, Gmbh & Co, Kg Method for producing metal and ceramic sintered bodies and coatings
US5595750A (en) * 1991-08-09 1997-01-21 E. I. Du Pont De Nemours And Company Antimicrobial particles of silver and barium sulfate or zinc oxide
US5814272A (en) * 1996-02-21 1998-09-29 Millipore Corporation Method for forming dendritic metal particles
US5837275A (en) * 1992-05-19 1998-11-17 Westaim Technologies, Inc. Anti-microbial materials
US5895419A (en) * 1996-09-30 1999-04-20 St. Jude Medical, Inc. Coated prosthetic cardiac device
US6123731A (en) * 1998-02-06 2000-09-26 Osteotech, Inc. Osteoimplant and method for its manufacture

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4476590A (en) * 1980-03-27 1984-10-16 National Research Development Corporation Antimicrobial surgical implants
AT379296B (en) * 1980-11-03 1985-12-10 Hirsch Hermann Leder Kunstst Subject of particularly flexible material
NO146306C (en) * 1980-12-09 1982-09-08 Tor Christiansen Bone cement and the use thereof.
DE3110681C2 (en) * 1981-03-19 1988-03-24 Juergen Dr.Med. 5024 Brauweiler De Eitenmueller
DE3228849C2 (en) * 1982-08-02 1989-06-08 Fraunhofer-Gesellschaft Zur Foerderung Der Angewandten Forschung E.V., 8000 Muenchen, De
WO1984001721A1 (en) * 1982-11-05 1984-05-10 Baxter Travenol Lab Antimicrobial compositions
JPS6354013B2 (en) * 1983-01-21 1988-10-26 Kanebo Kk
US4828832A (en) * 1983-09-07 1989-05-09 Laboratorios Biochemie De Mexico Method of manufacturing a composition for treating skin lesions
GB8616294D0 (en) * 1986-07-03 1986-08-13 Johnson Matthey Plc Antimicrobial compositions
US4849233A (en) 1987-11-12 1989-07-18 Hemker Leonard E Meltable coating and binder composition for popped corn kernels
JP2883741B2 (en) * 1990-12-10 1999-04-19 大日本塗料株式会社 Dental cement curing agent
JP3057773B2 (en) * 1991-02-05 2000-07-04 不二製油株式会社 Pie method of manufacture
US5520664A (en) * 1991-03-01 1996-05-28 Spire Corporation Catheter having a long-lasting antimicrobial surface treatment
US5180585A (en) * 1991-08-09 1993-01-19 E. I. Du Pont De Nemours And Company Antimicrobial compositions, process for preparing the same and use
AT155649T (en) * 1994-02-01 1997-08-15 Theodor Krall A process for producing bactericidal / fungicidal plastic bodies
USH1732H (en) * 1994-03-10 1998-06-02 Johnson; Theresa Louise Absorbent articles containing antibacterial agents in the topsheet for odor control
US5829442A (en) * 1996-06-12 1998-11-03 Medical Concepts Development, Inc. Antimicrobial containing solventless hot melt adhesive composition
FR2755612B1 (en) * 1996-11-13 1998-12-24 Atochem Elf Sa superabsorbent composition for hygiene articles do not developping unpleasant odors
US6267782B1 (en) * 1997-11-20 2001-07-31 St. Jude Medical, Inc. Medical article with adhered antimicrobial metal
DE19751581C2 (en) 1997-11-20 2002-05-08 Thorsten Bechert Method and apparatus for testing of materials with respect to their potential antimicrobial activity and adhesion on their surface
US6124374A (en) * 1998-05-29 2000-09-26 Block Drug Company, Inc. Antimicrobial denture adhesive and cleanser compositions
BR9915174A (en) * 1998-11-09 2001-11-06 Ira Jay Newman silver complex iÈnica
EP1066825A1 (en) * 1999-06-17 2001-01-10 THE PROCTER & GAMBLE COMPANY An anti-microbial body care product
US6303183B1 (en) * 1999-11-08 2001-10-16 Aos Holding Company Anti-microbial porcelain enamel coating
DE10043151A1 (en) * 2000-08-31 2002-03-28 Peter Steinruecke Bone cement with antimicrobial activity
CA2445729C (en) * 2001-04-23 2013-07-02 Nucryst Pharmaceuticals Corp. Use of metals to treat mucosal membranes
DE10146050B4 (en) * 2001-09-18 2007-11-29 Bio-Gate Ag A process for producing an antimicrobial adhesive and coating material
DE10205600B4 (en) * 2002-02-11 2005-06-23 Bio-Gate Bioinnovative Materials Gmbh An absorbent hygiene product for absorbing body fluid
DE10340277B4 (en) * 2003-08-29 2006-11-23 Bio-Gate Bioinnovative Materials Gmbh Personal care products with silver agglomerates
DE10340276B4 (en) * 2003-08-29 2006-11-09 Bio-Gate Bioinnovative Materials Gmbh Personal care products with silver and zinc
DE102004001594B4 (en) * 2004-01-09 2006-09-21 Bio-Gate Ag Wound dressing and methods for their preparation
CA2456362C (en) * 2004-01-27 2012-11-27 Bio-Gate Bioinnovative Materials Gmbh Absorbent sanitary article comprising metallic silver for absorbing body fluid

Patent Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4592920A (en) * 1983-05-20 1986-06-03 Baxter Travenol Laboratories, Inc. Method for the production of an antimicrobial catheter
US4849223A (en) * 1984-12-28 1989-07-18 Johnson Matthey Public Limited Company Antimicrobial compositions consisting of metallic silver combined with titanium oxide or tantalum oxide
US5356629A (en) * 1991-07-12 1994-10-18 United States Surgical Corporation Composition for effecting bone repair
US5595750A (en) * 1991-08-09 1997-01-21 E. I. Du Pont De Nemours And Company Antimicrobial particles of silver and barium sulfate or zinc oxide
US5171579A (en) * 1991-10-11 1992-12-15 Genetics Institute, Inc. Formulations of blood clot-polymer matrix for delivery of osteogenic proteins
US5837275A (en) * 1992-05-19 1998-11-17 Westaim Technologies, Inc. Anti-microbial materials
US5590387A (en) * 1993-10-27 1996-12-31 H. C. Starck, Gmbh & Co, Kg Method for producing metal and ceramic sintered bodies and coatings
US5814272A (en) * 1996-02-21 1998-09-29 Millipore Corporation Method for forming dendritic metal particles
US5895419A (en) * 1996-09-30 1999-04-20 St. Jude Medical, Inc. Coated prosthetic cardiac device
US6123731A (en) * 1998-02-06 2000-09-26 Osteotech, Inc. Osteoimplant and method for its manufacture

Cited By (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7998054B2 (en) 1997-10-09 2011-08-16 Thoratec Corporation Implantable heart assist system and method of applying same
US20100016960A1 (en) * 1997-10-09 2010-01-21 Bolling Steven F Implantable Heart Assist System And Method Of Applying Same
US20090010981A1 (en) * 2000-08-31 2009-01-08 Bio-Gate Ag Antimicrobial material for implanting in bones
US20070213679A1 (en) * 2002-02-11 2007-09-13 Bio-Gate Bioinnovative Materials Gmbh Absorbent sanitary article for absorbing body fluid
US7910796B2 (en) 2002-02-11 2011-03-22 Bio-Gate Ag Absorbent sanitary article for absorbing body fluid
US20090275907A1 (en) * 2002-02-11 2009-11-05 Bio-Gate Ag Absorbent sanitary article for absorbing body fluid
US8067663B2 (en) 2002-02-11 2011-11-29 Bio-Gate Ag Absorbent sanitary article for absorbing body fluid
US20060105010A1 (en) * 2002-10-12 2006-05-18 Martin Rahe Bladder implant
US20070081958A1 (en) * 2003-08-29 2007-04-12 Thorsten Bechert Body care product containing porous silver particles
US8684902B2 (en) 2003-09-18 2014-04-01 Thoratec Corporation Rotary blood pump
US20080095648A1 (en) * 2003-09-18 2008-04-24 Wampler Richard K Rotary Blood Pump
US20080089797A1 (en) * 2003-09-18 2008-04-17 Wampler Richard K Rotary Blood Pump
US20100135832A1 (en) * 2003-09-18 2010-06-03 Wampler Richard K Rotary Blood Pump
US8118724B2 (en) 2003-09-18 2012-02-21 Thoratec Corporation Rotary blood pump
US8992163B2 (en) 2004-09-17 2015-03-31 Thoratec Corporation Expandable impeller pump
US8376707B2 (en) 2004-09-17 2013-02-19 Thoratec Corporation Expandable impeller pump
US10215187B2 (en) 2004-09-17 2019-02-26 Tc1 Llc Expandable impeller pump
US7927068B2 (en) 2004-09-17 2011-04-19 Thoratec Corporation Expandable impeller pump
US20090060743A1 (en) * 2004-09-17 2009-03-05 The Penn State Research Foundation Expandable impeller pump
US20110236210A1 (en) * 2004-09-17 2011-09-29 The Penn State Research Foundation Expandable impeller pump
US9364592B2 (en) 2004-09-17 2016-06-14 The Penn State Research Foundation Heart assist device with expandable impeller pump
US9364593B2 (en) 2004-09-17 2016-06-14 The Penn State Research Foundation Heart assist device with expandable impeller pump
US9717833B2 (en) 2004-09-17 2017-08-01 The Penn State Research Foundation Heart assist device with expandable impeller pump
US20090191260A1 (en) * 2006-02-23 2009-07-30 Bio-Gate Ag Aerosol and use thereof
US7841976B2 (en) 2006-03-23 2010-11-30 Thoratec Corporation Heart assist device with expandable impeller pump
US10149932B2 (en) 2006-03-23 2018-12-11 The Penn State Research Foundation Heart assist device with expandable impeller pump
US20080114339A1 (en) * 2006-03-23 2008-05-15 The Penn State Research Foundation Heart assist device with expandable impeller pump
US20070231135A1 (en) * 2006-03-31 2007-10-04 Orqis Medical Corporation Rotary Blood Pump
US9512852B2 (en) 2006-03-31 2016-12-06 Thoratec Corporation Rotary blood pump
US20100136073A1 (en) * 2007-04-18 2010-06-03 Ciba Corporation Antimicrobial plastics and coatings
US8535211B2 (en) 2009-07-01 2013-09-17 Thoratec Corporation Blood pump with expandable cannula
US8684904B2 (en) 2009-07-01 2014-04-01 Thoratec Corporation Blood pump with expandable cannula
US20110004046A1 (en) * 2009-07-01 2011-01-06 The Penn State Research Foundation Blood pump with expandable cannula
US8485961B2 (en) 2011-01-05 2013-07-16 Thoratec Corporation Impeller housing for percutaneous heart pump
US8597170B2 (en) 2011-01-05 2013-12-03 Thoratec Corporation Catheter pump
US9138518B2 (en) 2011-01-06 2015-09-22 Thoratec Corporation Percutaneous heart pump
US9962475B2 (en) 2011-01-06 2018-05-08 Tc1 Llc Percutaneous heart pump
US8591393B2 (en) 2011-01-06 2013-11-26 Thoratec Corporation Catheter pump
WO2012123273A1 (en) 2011-03-11 2012-09-20 Basf Se Antimicrobial coating
US9872947B2 (en) 2012-05-14 2018-01-23 Tc1 Llc Sheath system for catheter pump
US9446179B2 (en) 2012-05-14 2016-09-20 Thoratec Corporation Distal bearing support
US10117980B2 (en) 2012-05-14 2018-11-06 Tc1 Llc Distal bearing support
US9675740B2 (en) 2012-05-14 2017-06-13 Tc1 Llc Impeller for catheter pump
US8721517B2 (en) 2012-05-14 2014-05-13 Thoratec Corporation Impeller for catheter pump
US10039872B2 (en) 2012-05-14 2018-08-07 Tc1 Llc Impeller for catheter pump
US9327067B2 (en) 2012-05-14 2016-05-03 Thoratec Corporation Impeller for catheter pump
US10086121B2 (en) 2012-07-03 2018-10-02 Tc1 Llc Catheter pump
US9358329B2 (en) 2012-07-03 2016-06-07 Thoratec Corporation Catheter pump
US9421311B2 (en) 2012-07-03 2016-08-23 Thoratec Corporation Motor assembly for catheter pump
US9833472B2 (en) 2012-11-16 2017-12-05 Heraeus Medical Gmbh Antiseptic polymethylmethacrylate bone cement
US9381288B2 (en) 2013-03-13 2016-07-05 Thoratec Corporation Fluid handling system
US9308302B2 (en) 2013-03-15 2016-04-12 Thoratec Corporation Catheter pump assembly including a stator
US10105475B2 (en) 2014-04-15 2018-10-23 Tc1 Llc Catheter pump introducer systems and methods
US10029037B2 (en) 2014-04-15 2018-07-24 Tc1 Llc Sensors for catheter pumps
US9827356B2 (en) 2014-04-15 2017-11-28 Tc1 Llc Catheter pump with access ports
US9987404B2 (en) 2015-01-22 2018-06-05 Tc1 Llc Motor assembly with heat exchanger for catheter pump
US9675739B2 (en) 2015-01-22 2017-06-13 Tc1 Llc Motor assembly with heat exchanger for catheter pump
US9770543B2 (en) 2015-01-22 2017-09-26 Tc1 Llc Reduced rotational mass motor assembly for catheter pump
US9675738B2 (en) 2015-01-22 2017-06-13 Tc1 Llc Attachment mechanisms for motor of catheter pump
US9907890B2 (en) 2015-04-16 2018-03-06 Tc1 Llc Catheter pump with positioning brace

Also Published As

Publication number Publication date
DE50115272D1 (en) 2010-02-04
US20090010981A1 (en) 2009-01-08
EP1621217B8 (en) 2016-09-14
DE10043151A1 (en) 2002-03-28
EP1313518B1 (en) 2009-12-23
EP1621217B1 (en) 2016-04-20
ES2337126T3 (en) 2010-04-21
US6984392B2 (en) 2006-01-10
EP1621217A3 (en) 2006-06-28
EP1621217A2 (en) 2006-02-01
AU9161101A (en) 2002-03-13
WO2002017984A1 (en) 2002-03-07
US20030165556A1 (en) 2003-09-04
ES2582940T3 (en) 2016-09-16
EP1313518A1 (en) 2003-05-28

Similar Documents

Publication Publication Date Title
Arcos et al. Sol–gel silica-based biomaterials and bone tissue regeneration
Fielding et al. Effects of silica and zinc oxide doping on mechanical and biological properties of 3D printed tricalcium phosphate tissue engineering scaffolds
Chen et al. Antibacterial and osteogenic properties of silver‐containing hydroxyapatite coatings produced using a sol gel process
Nishiguchi et al. Biology of alkali‐and heat‐treated titanium implants
Li et al. Mg–Zr–Sr alloys as biodegradable implant materials
US4917702A (en) Bone replacement material on the basis of carbonate and alkali containing calciumphosphate apatites
CN1276748C (en) Biofunctional hydroxyapatite coatings and microspheres for in-situ drug encapsulation
US8597604B2 (en) Tricalcium phosphates, their composites, implants incorporating them, and methods for their production
Yan et al. Apatite layer-coated titanium for use as bone bonding implants
Narayan Biomedical materials
Cao et al. Bioactive materials
Ohgaki et al. Manipulation of selective cell adhesion and growth by surface charges of electrically polarized hydroxyapatite
CN100515504C (en) Coating, coated articles and methods of manufacture thereof
EP1385449B1 (en) Biologically-functionalised, metabolically-inductive implant surfaces
US6479565B1 (en) Bioactive ceramic cement
Pezzatini et al. The effect of hydroxyapatite nanocrystals on microvascular endothelial cell viability and functions
Ferraz et al. Nanohydroxyapatite microspheres as delivery system for antibiotics: release kinetics, antimicrobial activity, and interaction with osteoblasts
Takechi et al. Effects of added antibiotics on the basic properties of anti‐washout‐type fast‐setting calcium phosphate cement
Hamanishi et al. A self‐setting TTCP‐DCPD apatite cement for release of vancomycin
CA1297796C (en) Zcap ceramics
Jones et al. Bioactive glass scaffolds for bone regeneration
JP4606165B2 (en) Biocompatible implants for titanium oxide coatings and methods for their preparation resistant to infection
Belt et al. Infection of orthopedic implants and the use of antibiotic-loaded bone cements: a review
Oktar et al. Sintering effects on mechanical properties of glass-reinforced hydroxyapatite composites
Juan et al. Deposition of silver nanoparticles on titanium surface for antibacterial effect

Legal Events

Date Code Title Description
AS Assignment

Owner name: BIO-GATE AG, GERMANY

Free format text: MERGER;ASSIGNOR:BIO-GATE BIOINNOVATIVE MATERIALS GMBH;REEL/FRAME:018688/0370

Effective date: 20051215